Dreama Cleaver v. HHS - Tdap, shoulder injury related to vaccine administration (SIRVA) (2024)

Dreama Cleaver filed a petition for compensation under the National Vaccine Injury Compensation Program on February 21, 2023, alleging she suffered a shoulder injury related to vaccine administration (SIRVA) resulting from a Tdap vaccine received on February 24, 2022. She claimed the injury was a Table injury, that it occurred in the United States, that she experienced residual effects for more than six months, and that there had been no prior award or settlement for this condition.

The respondent denied that Ms. Cleaver sustained a SIRVA Table injury or that the vaccine caused her alleged shoulder injury.

Despite these denials, the parties filed a joint stipulation on September 24, 2024, agreeing to settle the case and award compensation. Chief Special Master Corcoran adopted the stipulation as the decision, awarding Ms.

Cleaver a lump sum of $35,000.00 for all damages. This amount represents compensation for all items of damages available under Section 15(a) of the Vaccine Act.

The parties also agreed to proceedings for attorneys' fees and costs.